Evid Invest
Who owns IOVAWhat IOVA owns — n/a

Who owns IOVANCE BIOTHERAPEUTICS, INC.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of IOVA from SEC Form 13F filings across 334 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 334 institutions disclosed 277.5M shares of IOVANCE BIOTHERAPEUTICS, INC. worth $4.11B — about 60.9% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.

334

13F holders

$4.11B

value, 2026 filers

60.9%

of shares outstanding (277.5M sh)

78

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of IOVA's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1BlackRock, Inc.37.9M$561.7M0.0%8.3%+2.6%
2MHR FUND MANAGEMENT LLC29.0M$429.3M21.1%6.4%0.0%
3STATE STREET CORP21.7M$321.5M0.0%4.8%-11.4%
4VANGUARD CAPITAL MANAGEMENT LLC18.4M$272.6M0.0%4%+1.1%
5TWO SIGMA INVESTMENTS, LP15.0M$221.8M0.2%3.3%-21.3%
6VANGUARD PORTFOLIO MANAGEMENT LLC12.3M$182.0M0.0%2.7%-14.7%
7GEODE CAPITAL MANAGEMENT, LLC10.5M$154.9M0.0%2.3%+1.2%
8D. E. Shaw & Co., Inc.9.2M$135.8M0.1%2%+327.6%
9DIMENSIONAL FUND ADVISORS LP6.2M$92.4M0.0%1.4%-3.4%
10GOLDMAN SACHS GROUP INC4.9M$73.2M0.0%1.1%-3.1%
11Nuveen, LLC4.7M$68.9M0.0%1%-6.9%
12MORGAN STANLEY4.5M$66.5M0.0%1%-10.1%
13JANE STREET GROUP, LLC4.2M$61.9M0.0%0.9%-5.0%
14NORTHERN TRUST CORP4.1M$60.7M0.0%0.9%-1.4%
15BANK OF AMERICA CORP /DE/4.0M$59.8M0.0%0.9%-19.2%
16AQR CAPITAL MANAGEMENT LLC3.7M$55.5M0.0%0.8%-3.3%
17JUPITER ASSET MANAGEMENT LTD3.7M$54.5M0.3%0.8%-18.9%
18CHARLES SCHWAB INVESTMENT MANAGEMENT INC3.6M$53.4M0.0%0.8%+11.9%
19Palo Alto Investors LP3.5M$51.4M7.7%0.8%-34.5%
20MPM BIOIMPACT LLCNEW2.8M$42.0M3.1%0.6%new
21WELLS FARGO & COMPANY/MN2.8M$41.2M0.0%0.6%-14.3%
22VANGUARD FIDUCIARY TRUST CO2.7M$39.3M0.0%0.6%+4.2%
23UBS Group AG2.6M$37.8M0.0%0.6%+97.5%
24JPMORGAN CHASE & CO2.5M$36.6M0.0%0.6%+4.2%
25Rhenman & Partners Asset Management AB2.5M$37.1M4.1%0.5%+46.8%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.
EvidInvest Pro: unlimited filings data, $50/month